Analytical Services in Discovery, Early Development & Development


NON-GLP OR GLP

Type of Service

Endpoints

Method development / validation

Method development /analysis for screening PK

 

GLP-method development

 

Stability in formulations

 

Stability in plasma/serum

Analysis

Bioanalysis GLP or non-GLP

 

Metabolite screens (12C or 14C)

 

Radio-analysis (preclinical or clinical)

 

Metabolite ID

 

PK regulatory (single or repeated dose)

* 3rd party supplier

 

Contact

Business Development
Please send us an Email!



Exhibitions

EBD
Bio Europe Spring
25.03 - 27.03.2019
Vienna / Austria


Euro Biosimilars
12th European Biosimilars Congress
15.04 - 16.04.2019
Berlin / Germany


Swiss Biotech
Swiss Biotech Day 2018
07.05.2019
Basel / Switzerland